HEALTHCARE
Global Perfusion Systems Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Perfusion Systems Market, By Component (Oxygenators, Heart-Lung Machine, Perfusion Pumps, Monitoring System, Bioreactor Perfusion System, Others), Type (Bioreactor Perfusion Systems, Microfluidic Perfusion Systems, Gravity or Pressure-Driven Perfusion Systems, Small-Mammal Organ Perfusion Systems), Technique (Hypothermic Machine Perfusion and Normothermic Machine Perfusion), Application (Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System), End-use (Hospitals, Ambulatory Surgical Centers, Others), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global perfusion systems market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.
Perfusion systems are medical devices used in surgical procedures and conditions needing artificial organ support. They are intended to circulate blood or other fluids through organs and tissues. These systems sustain the survival of organs and tissues by ensuring the flow of nutrients and oxygen and by eliminating waste products. The perfusion systems market includes the development, manufacture, and sale of a wide range of perfusion equipment, such as heart-lung machines, oxygenators, perfusion pumps, and other related devices. It entails substantial study and invention to improve the efficiency, safety, and dependability of these systems. The market also comprises services like installation, maintenance, and training for healthcare workers, which cater to hospitals, surgery centers, and research organizations all over the world.
The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
- Increasing number of organ transplant procedures.
- Growing geriatric population.
RESTRAINTS
- High cost of perfusion systems.
- Stringent regulatory requirements.
OPPORTUNITIES
- Emerging markets with increasing healthcare investments.
- Development of portable and user-friendly perfusion systems.
CHALLENGES
- Ensuring the availability of donor organs.
- Managing the complexity of perfusion procedures.
SEGMENTATION
- Component
- Oxygenators
- Heart-Lung Machine
- Perfusion Pumps
- Monitoring System
- Bioreactor Perfusion System
- Others
- Type
- Bioreactor Perfusion Systems
- Microfluidic Perfusion Systems
- Gravity or Pressure-Driven Perfusion Systems
- Small-Mammal Organ Perfusion Systems
- Technique
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Application
- Cardiopulmonary Perfusion System
- Cell Perfusion System
- Ex-Vivo Organ Perfusion System
- End-use
- Hospitals
- Ambulatory Surgical Centers
- Others
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Getinge AB
- Medtronic PLC
- Livanova PLC
- Terumo Corporation
- Nipro Corporation
- Xenios AG
- Repligen Corporation
- Spectrum Laboratories, Inc.
- Merck KGaA
- Harvard Bioscience, Inc.
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Perfusion Systems Market, by Component
- 3.2 Global Perfusion Systems Market, by Type
- 3.3 Global Perfusion Systems Market, by Technique
- 3.4 Global Perfusion Systems Market, by Application
- 3.5 Global Perfusion Systems Market, by End-use
- 3.6 Global Perfusion Systems Market, by Geography
- 3.7 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Growing focus on personalized medicine.
- 5.1.2 Technological advancements in perfusion systems.
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Increasing number of organ transplant procedures.
- 5.2.2 Growing geriatric population.
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 High cost of perfusion systems.
- 5.3.2 Stringent regulatory requirements.
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Emerging markets with increasing healthcare investments.
- 5.4.2 Development of portable and user-friendly perfusion systems.
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Ensuring the availability of donor organs.
- 5.5.2 Managing the complexity of perfusion procedures.
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL PERFUSION SYSTEMS MARKET, BY COMPONENT
- 6.1 Component Summary
- 6.2 Market Attractive Index
- 6.3 Global Perfusion Systems Market, by Component (2019-2032)
- SECTION 7 - GLOBAL PERFUSION SYSTEMS MARKET, BY TYPE
- 7.1 Type Summary
- 7.2 Market Attractive Index
- 7.3 Global Perfusion Systems Market, by Type (2019-2032)
- SECTION 8 - GLOBAL PERFUSION SYSTEMS MARKET, BY TECHNIQUE
- 8.1 Technique Summary
- 8.2 Market Attractive Index
- 8.3 Global Perfusion Systems Market, by Technique (2019-2032)
- SECTION 9 - GLOBAL PERFUSION SYSTEMS MARKET, BY APPLICATION
- 9.1 Application Summary
- 9.2 Market Attractive Index
- 9.3 Global Perfusion Systems Market, by Application (2019-2032)
- SECTION 10 - GLOBAL PERFUSION SYSTEMS MARKET, BY END-USE
- 10.1 End-use Summary
- 10.2 Market Attractive Index
- 10.3 Global Perfusion Systems Market, by End-use (2019-2032)
- SECTION 11 - GLOBAL PERFUSION SYSTEMS MARKET, BY GEOGRAPHY
- 11.1 Regional Summary
- 11.2 Market Attractive Index
- 11.3 Global Perfusion Systems Market, by Geography (2019-2032)
- SECTION 12 - NORTH AMERICA PERFUSION SYSTEMS MARKET
- 12.1 North America Summary
- 12.2 Market Attractive Index
- 12.3 North America Perfusion Systems Market, by Component (2019-2032)
- 12.4 North America Perfusion Systems Market, by Type (2019-2032)
- 12.5 North America Perfusion Systems Market, by Technique (2019-2032)
- 12.6 North America Perfusion Systems Market, by Application (2019-2032)
- 12.7 North America Perfusion Systems Market, by End-use (2019-2032)
- 12.8 North America Perfusion Systems Market, by Country (2019-2032)
- 12.8.1 U.S.
- 12.8.2 Canada
- 12.8.3 Mexico
- 12.8.4 Rest of North America
- SECTION 13 - EUROPE PERFUSION SYSTEMS MARKET
- 13.1 Europe Summary
- 13.2 Market Attractive Index
- 13.3 Europe Perfusion Systems Market, by Component (2019-2032)
- 13.4 Europe Perfusion Systems Market, by Type (2019-2032)
- 13.5 Europe Perfusion Systems Market, by Technique (2019-2032)
- 13.6 Europe Perfusion Systems Market, by Application (2019-2032)
- 13.7 Europe Perfusion Systems Market, by End-use (2019-2032)
- 13.8 Europe Perfusion Systems Market, by Country (2019-2032)
- 13.8.1 Germany
- 13.8.2 U.K.
- 13.8.3 France
- 13.8.4 Italy
- 13.8.5 Spain
- 13.8.6 Russia
- 13.8.7 The Netherlands
- 13.8.8 Belgium
- 13.8.9 Turkey
- 13.8.10 Rest of Europe
- SECTION 14 - ASIA-PACIFIC PERFUSION SYSTEMS MARKET
- 14.1 Asia-Pacific Summary
- 14.2 Market Attractive Index
- 14.3 Asia-Pacific Perfusion Systems Market, by Component (2019-2032)
- 14.4 Asia-Pacific Perfusion Systems Market, by Type (2019-2032)
- 14.5 Asia-Pacific Perfusion Systems Market, by Technique (2019-2032)
- 14.6 Asia-Pacific Perfusion Systems Market, by Application (2019-2032)
- 14.7 Asia-Pacific Perfusion Systems Market, by End-use (2019-2032)
- 14.8 Asia-Pacific Perfusion Systems Market, by Country (2019-2032)
- 14.8.1 China
- 14.8.2 India
- 14.8.3 Japan
- 14.8.4 South Korea
- 14.8.5 Singapore
- 14.8.6 Malaysia
- 14.8.7 Australia
- 14.8.8 Thailand
- 14.8.9 Philippines
- 14.8.10 Rest of Asia-Pacific
- SECTION 15 - SOUTH AMERICA PERFUSION SYSTEMS MARKET
- 15.1 South America Summary
- 15.2 Market Attractive Index
- 15.3 South America Perfusion Systems Market, by Component (2019-2032)
- 15.4 South America Perfusion Systems Market, by Type (2019-2032)
- 15.5 South America Perfusion Systems Market, by Technique (2019-2032)
- 15.6 South America Perfusion Systems Market, by Application (2019-2032)
- 15.7 South America Perfusion Systems Market, by End-use (2019-2032)
- 15.8 South America Perfusion Systems Market, by Country (2019-2032)
- 15.8.1 Brazil
- 15.8.2 Argentina
- 15.8.3 Chile
- 15.8.4 Colombia
- 15.8.5 Rest of South America
- SECTION 16 - MIDDLE EAST AND AFRICA PERFUSION SYSTEMS MARKET
- 16.1 Middle East and Africa Summary
- 16.2 Market Attractive Index
- 16.3 Middle East and Africa Perfusion Systems Market, by Component (2019-2032)
- 16.4 Middle East and Africa Perfusion Systems Market, by Type (2019-2032)
- 16.5 Middle East and Africa Perfusion Systems Market, by Technique (2019-2032)
- 16.6 Middle East and Africa Perfusion Systems Market, by Application (2019-2032)
- 16.7 Middle East and Africa Perfusion Systems Market, by End-use (2019-2032)
- 16.8 Middle East and Africa Perfusion Systems Market, by Country (2019-2032)
- 16.8.1 Kingdom of Saudi Arabia
- 16.8.2 South Africa
- 16.8.3 U.A.E.
- 16.8.4 Egypt
- 16.8.5 Rest of Middle East and Africa
- SECTION 17 - COMPANY SHARE ANALYSIS
- 17.1 Global Perfusion Systems Market, Company Share Analysis
- 17.2 North America Perfusion Systems Market, Company Share Analysis
- 17.3 Europe Perfusion Systems Market, Company Share Analysis
- 17.4 Asia-Pacific Perfusion Systems Market, Company Share Analysis
- SECTION 18 - COMPANY PROFILES
- 18.1 Getinge AB
- 18.1.1 Company Snapshot
- 18.1.2 Financial Overview
- 18.1.3 Product Portfolio
- 18.1.4 Recent Developments
- 18.2 Medtronic PLC
- 18.2.1 Company Snapshot
- 18.2.2 Financial Overview
- 18.2.3 Product Portfolio
- 18.2.4 Recent Developments
- 18.3 Livanova PLC
- 18.3.1 Company Snapshot
- 18.3.2 Financial Overview
- 18.3.3 Product Portfolio
- 18.3.4 Recent Developments
- 18.4 Terumo Corporation
- 18.4.1 Company Snapshot
- 18.4.2 Financial Overview
- 18.4.3 Product Portfolio
- 18.4.4 Recent Developments
- 18.5 Nipro Corporation
- 18.5.1 Company Snapshot
- 18.5.2 Financial Overview
- 18.5.3 Product Portfolio
- 18.5.4 Recent Developments
- 18.6 Xenios AG
- 18.6.1 Company Snapshot
- 18.6.2 Financial Overview
- 18.6.3 Product Portfolio
- 18.6.4 Recent Developments
- 18.7 Repligen Corporation
- 18.7.1 Company Snapshot
- 18.7.2 Financial Overview
- 18.7.3 Product Portfolio
- 18.7.4 Recent Developments
- 18.8 Spectrum Laboratories, Inc.
- 18.8.1 Company Snapshot
- 18.8.2 Financial Overview
- 18.8.3 Product Portfolio
- 18.8.4 Recent Developments
- 18.9 Merck KGaA
- 18.9.1 Company Snapshot
- 18.9.2 Financial Overview
- 18.9.3 Product Portfolio
- 18.9.4 Recent Developments
- 18.10 Harvard Bioscience, Inc.
- 18.10.1 Company Snapshot
- 18.10.2 Financial Overview
- 18.10.3 Product Portfolio
- 18.10.4 Recent Developments
- SECTION 19 - RELATED REPORTS
- SECTION 20 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.